B of A Securities analyst Cameron Lochridge initiates coverage on New Fortress Energy (NASDAQ:NFE) with a Buy rating and announces Price Target of $67.
Cantor Fitzgerald analyst Rick Bienkowski initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Overweight rating and announces Price Target of $67.
Cantor Fitzgerald analyst Rick Bienkowski initiates coverage on Beam Therapeutics (NASDAQ:BEAM) with a Overweight rating and announces Price Target of $62.